Prefilled Syringes Market: Growth, Size, Share, and Trends

Report Code MD 4755
Published in Jul, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), & Region - Global Forecast to 2030

Overview

The global prefilled syringes market, valued at US$5.7 billion in 2022, is forecasted to grow at a robust CAGR of 10.8%, reaching US$7.1 billion in 2024 and an impressive US$13.1 billion by 2030. The market for prefilled syringes is expanding significantly as a result of rising chronic illness rates that necessitate frequent treatment, and growing demand for effective and practical drug delivery methods. Healthcare settings are adopting these syringes because of their benefits, which include decreased drug errors, exact dosing, and improved patient safety. Further driving the market expansion is the increased emphasis on self-administration, as well as regulatory support for safer injection methods. A prefilled syringe is a convenient medical device for delivering parenteral medications, offering a premeasured single-dose. This syringe benefits manufacturers by minimizing drug waste and extending product lifespan, while also making self-administration easier for patients at home or outside of hospital settings. Drugs commonly packaged in prefilled syringes include biologics, vaccines, blood stimulants, therapeutic proteins, erythropoietin products, and interferons.

Attractive Opportunities in the Prefilled Syringes Market

ASIA PACIFIC:

Market growth in the Asia Pacific region can be attributed to increasing prevalence of chronic diseases, rapidly expanding pharmaceutical industry, and the growing healthcare infrastructure.

The rising incidence of chronic diseases such as diabetes, cancer, and cardiovascular diseases necessitates the development of more effective and targeted drug delivery methods. Prefilled syringes offer precise dosing and enhance therapeutic outcomes.

Emerging economies with increasing investments from government bodies and key players are expected to offer growth opportunities for market players during the forecast period in the Asia Pacific region.

The Asia Pacific market is expected to be worth USD 3.1 billion by 2030, growing at CAGR of 12.3% during the forecast period.

Rising healthcare needs, increasing technological advancements, and growing healthcare infrastructure to contribute to the market growth of prefilled syringes.

Global Prefilled Syringes Market Dynamics

DRIVER: Increasing prevalence of chronic diseases

The prefilled syringes market growth is largely being driven by the rising prevalence of chronic diseases like diabetes, cardiovascular disease, and autoimmune disorders. Prefilled syringes provide a practical, safe, and effective alternative for patients and healthcare professionals alike, as these disorders frequently necessitate the exact and regular administration of drugs. They raise patient compliance, lower the possibility of dosage errors, and improve the standard of treatment. Prefilled syringes demand is further fueled by the growing trends in self-administration, especially with regard to biologics and biosimilars, which is driving the market's growth.

RESTRAINT: Impact of product recalls

Product recalls impede the prefilled syringe market's growth by eroding consumer confidence in these medical products. Manufacturers suffer significant financial losses as a result of recalls, which are frequently caused by contamination, or safety hazards. These losses also stem from potential legal obligations. They may also interfere with supply chains, leading to delays and shortages that impact patients and healthcare providers. All of these factors impede the market growth and impact the general uptake of prefilled syringes.

 

OPPORTUNITY: Increasing demand for biologics and biosimilars

The market for pre-filled syringes has a significant opportunity due to the growing need for biologics and biosimilars. A growing number of people are using biologics, complex drugs made from living things, and biosimilars to treat chronic illnesses. Pre-filled syringes provide a practical and accurate option because these therapies need precise and dependable delivery techniques to guarantee efficacy and patient safety. The market for pre-filled syringes is expected to rise significantly due to their capacity to lower dose errors, increase patient compliance, and improve overall healthcare outcomes. These benefits perfectly complement the growing usage of biologics and biosimilars.

CHALLENGE: Alternative drug delivery methods

In the pre-filled syringe market, alternative drug administration technologies pose a serious threat by providing several options that may be seen as more practical or efficient for particular medical conditions. Various technologies like as autoinjectros, pen injectors, needle-free injectors, transdermal patches, and oral medication formulations offer various benefits like pain reduction, user-friendliness, and increased patient adherence. These substitutes may lessen the need for pre-filled syringes since patients and medical professionals may favor techniques that make injections less uncomfortable or simpler to use. As a result, in order for the pre-filled syringe business to be competitive, it must constantly innovate and highlight its advantages.

Global Prefilled Syringes Market Ecosystem Analysis

The prefilled syringe market ecosystem incorporates a number of players, including patients, healthcare professionals, regulatory agencies, manufacturers of medical devices, and pharmaceutical firms. Pharmaceutical businesses create and supply injectable drugs, which are subsequently filled by specialist manufacturers into syringes. These producers prioritize maintaining accuracy, sterility, and safety; to reduce the possibility of contamination and needlestick accidents, they frequently use cutting-edge technologies like needle safety devices. The main consumers of these devices are healthcare professionals, such as clinics and hospitals, who depend on their dependability and simplicity to improve patient care. Particularly for chronic illnesses needing frequent injections, patients benefit from the pre-filled syringes' convenience of use and decreased risk of dose errors. Self-administration trends, which are fueled by patient preferences for at-home care and advancements in user-friendly design, also have an impact on the market. Advancements are driven by collaborations and partnerships across various entities, guaranteeing that the ecosystem adapts to meet the increasing needs for patient-centric solutions, safety, and efficiency.

 

By type, conventional prefilled syringes segment holds largest share in the prefilled syringes industry.

The prefilled syringes market, by type is dominated by the conventional prefilled syringes. These prefilled syringes are found in a wide range of medical settings such as clinics, hospitals, and home care settings. Their extensive use guarantees a consistent and high demand. These syringes are an appealing choice for healthcare providers looking to control expenses while preserving high-quality patient care because they are typically less expensive than more sophisticated or specialized needles. Furthermore, because conventional prefilled syringes are more convenient and require less preparation than traditional vial-and-syringe procedures, they typically improve patient compliance with treatment regimens. Conventional prefilled syringes have a large market penetration because of their extended shelf life and hence contributes to their dominant market share.By material, glasses prefilled syringes segment is expected to have the largest market share in the prefilled syringes industry.The dominance of the glass prefilled syringes segment can be attributed to several factor such as there is a lower possibility of medication interactions with these syringes, drug efficacy and integrity are ensured, which is especially important for expensive and sensitive biologics. Glass syringes are becoming more popular due to technological developments including better safety features and decreased breakage. Owing to this, pharmaceutical companies are favoring glass prefilled syringes more when it comes to administering injectable medicines, which has led to their significant market share.

By design, the single-chamber prefilled syringe segment is expected to dominate the prefilled syringes industry from 2024 to 2029.

The single-chamber prefilled syringe dominates the prefilled syringes market due its convenient features. The single-chamber prefilled syringe optimizes dosing accuracy, decreases preparation time, and minimizes contamination by combining the medicine and delivery mechanism into a single chamber. Its ease of use and effectiveness make it a desirable alternative for patients and healthcare providers alike, leading to higher acceptance and market share.By application, cancer segment is expected to have the largest market share in the prefilled syringes industry.In the prefilled syringes market, the cancer segment is holds the largest market share due to the rising incidence of cancer and the growing need for accurate and effective drug delivery methods for cancer treatments. Pre-filled syringes include benefits like lower dosing mistake risk, better patient compliance, and convenience, all of which are crucial for cancer therapies, which sometimes call for frequent and precise medicine administration. In addition, biologic therapies and chemotherapy are frequently employed in cancer therapy. Injectable formulations are used to give several of these therapies. Prefilled syringes provide a convenient option that minimizes dosage errors, saves preparation time, and improves patient safety. Thus, the use of prefilled syringes will grow as cancer treatments continue to advance and the need for effective drug delivery systems grows.

NORTH AMERICA Region Holds the Largest Share of the Prefilled Syringes Market.

The pre-filled syringe market is anticipated to be dominated by the North American region due to a number of factors, including an advanced healthcare infrastructure, a high prevalence of chronic diseases, and a focus on patient safety and technological innovation. Its dominant position in the market is also a result of the region's well-established pharmaceutical industry and rising demand for practical and precise drug delivery solutions. Furthermore, continued R&D expenditures and favorable regulatory environments in North America contribute to the expansion and use of pre-filled syringes.

 
 

Recent Developments of Prefilled Syringes Market industry

  • In April 2024, Baxter announced the expansion of its Pharmaceuticals portfolio with the launch of five new injectable products in the US. These launches focus on addressing unmet patient needs in key therapeutic areas, such as anti-infective and anti-hypotensive medications. In June 2024, SCHOTT Pharma (Germany) constructed a new production facility dedicated to prefillable glass syringes (PFS) at its location in Lukácsháza, Hungary. This strategic step demonstrated the company's proactive approach in offering advanced solutions for the storage of biologics, vaccines, and the newest generation of mRNA-based medications. In May 2023, Gerresheimer Glass GmbH, a subsidiary of Gerresheimer AG (Germany), signed a purchase agreement to acquire Bormioli Pharma Group. This acquisition strengthens Gerresheimer’s European presence and enhances its position in the pharmaceutical and biotech packaging market.
  • In May 2023, Baxter(US) signed a final agreement to sell its BioPharma Solutions (BPS) division to Advent International and Warburg Pincus, both renowned investment firms. This deal signifies the divestment of Baxter's contract development and manufacturing arm. In September 2022, BD (US) launched a next-generation glass prefillable syringe (PFS) that sets a new benchmark for vaccine performance by meeting tighter processability, cosmetics, contamination, and integrity requirements. Leading pharmaceutical companies collaborated to design the innovative BD Effivax Glass Prefillable Syringe to address the growing demand for vaccine manufacturing.

Key Market Players

KEY PLAYERS IN THE Prefilled Syringes Market INCLUDE

  • BD (US)
  • Gerresheimer AG (Germany)
  • SCHOTT (Germany)
  • West Pharmaceutical Services Inc. (US)
  • AptarGroup Inc. (US)
  • Nipro (Japan)
  • Baxter (US)
  • Owen Mumford Ltd. (UK)
  • Weigao Meidcal international Co. Ltd. (China)
  • Credence MedSystems Inc. (US)
  • Novartis AG (Switzerland)
  • Stevanato Group (Italy)
  • Polymedicure (India)
  • MedXL (Canada)
  • Sharps Technology Inc. (US)
  • Fresenius Kabi (US)
  • DBM S.R.L. (Italy)
  • Taisei Kako Co.,Ltd (Japan)
  • Shandong Province Medicinal Glass Co. Ltd. (China)
  • SHIN YAN SHENO PRECISION INDUSTRIAL CO. LTD (Japan)
  • J.O. PHARMA CO. LTD. (Japan)
  • BMIKOREA (Korea)
  • B. Braun SE (Germany)
  • Al Shifa Medical Products Co. (Saudi Arabia)

Want to explore hidden markets that can drive new revenue in Prefilled Syringes Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 $7.1 billion
Projected Revenue by 2030 $13.1 billion
Revenue Rate Poised to Grow at a CAGR of 10.8%
Market Driver Increasing prevalence of chronic diseases
Market Opportunity Increasing demand for biologics and biosimilars

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Prefilled Syringes Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
24
RESEARCH METHODOLOGY
30
EXECUTIVE SUMMARY
45
PREMIUM INSIGHTS
50
MARKET OVERVIEW
55
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing prevalence of chronic diseases
    - Growing adoption of self-injection devices
    - Increasing adoption of prefilled syringes in parenteral dosage forms
    - Increased use of biologics and vaccines
    - Technological advancements in prefilled syringes
    RESTRAINTS
    - Stringent government regulations
    - Impact of product recalls
    OPPORTUNITIES
    - Growing preference for unit-dose medication using prefilled syringes
    - Emerging markets with growing healthcare infrastructure
    CHALLENGES
    - Alternative drug delivery methods
    - Infections associated with needlestick injuries
  • 5.3 INDUSTRY TRENDS
    PREFILLED BIOLOGICS
    INTEGRATED SAFETY FEATURES
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Integration disinfection unit (IDU)
    COMPLEMENTARY TECHNOLOGIES
    - Cyclic olefin polymers (COP) and cyclic olefin copolymers (COC)
    ADJACENT TECHNOLOGIES
    - Integration with autoinjectors
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8 CASE STUDY ANALYSIS
    CASE STUDY 1: ENVIRONMENTAL BENEFITS OF USING PREFILLED ‘EMERGENCY’ DRUGS
    CASE STUDY 2: DEVELOPMENT OF NOVEL PHARMACEUTICAL DRUG MODALITIES REQUIRING FROZEN STORAGE AND TRANSPORTATION
  • 5.9 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF PREFILLED SYRINGES, BY TYPE, 2022–2024
    AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024
  • 5.10 UNMET NEEDS
  • 5.11 ECOSYSTEM ANALYSIS
  • 5.12 SUPPLY CHAIN ANALYSIS
  • 5.13 ADJACENT MARKET ANALYSIS
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.15 TRADE ANALYSIS
  • 5.16 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR PREFILLED SYRINGES
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PREFILLED SYRINGE PATENTS (JANUARY 2014−APRIL 2024)
    TOP APPLICANT COUNTRIES/REGIONS PATENTS FOR PREFILLED SYRINGES (JANUARY 2014−APRIL 2024)
  • 5.17 KEY CONFERENCES & EVENTS DURING 2024–2025
  • 5.18 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.19 INVESTMENT & FUNDING SCENARIO
  • 5.20 REIMBURSEMENT SCENARIO
  • 5.21 MARKET ANALYSIS OF PREFILLED SYRINGE COMPONENTS
    PLUNGER STOPPERS
PREFILLED SYRINGES MARKET, BY TYPE
89
  • 6.1 INTRODUCTION
  • 6.2 CONVENTIONAL PREFILLED SYRINGES
    DISPOSABLE PREFILLED SYRINGES
    - Increasing focus on patient safety to drive market
    REUSABLE PREFILLED SYRINGES
    - Cost-effectiveness and technological advancements to drive market
  • 6.3 SAFETY PREFILLED SYRINGES
    INTEGRATED SAFETY FEATURES TO BOOST ADOPTION
PREFILLED SYRINGES MARKET, BY DESIGN
99
  • 7.1 INTRODUCTION
  • 7.2 SINGLE-CHAMBER PREFILLED SYRINGES
    CONVENIENCE, SAFETY, AND EFFICIENCY OF SINGLE-CHAMBER SYRINGES TO SUPPORT MARKET GROWTH
  • 7.3 DUAL-CHAMBER PREFILLED SYRINGES
    UNIQUE ADVANTAGES AND SPECIFIC APPLICATIONS OF DUAL-CHAMBER SYRINGES TO DRIVE DEMAND
  • 7.4 CUSTOMIZED PREFILLED SYRINGES
    PATIENT-FRIENDLY FEATURES SUCH AS EASY-TO-READ DOSAGE INDICATORS AND SAFETY MECHANISMS TO BOOST ADOPTION
PREFILLED SYRINGES MARKET, BY MATERIAL
106
  • 8.1 INTRODUCTION
  • 8.2 GLASS PREFILLED SYRINGES
    ABILITY OF GLASS PREFILLED SYRINGES TO OFFER SUPERIOR BARRIER PROPERTIES TO BOOST MARKET GROWTH
  • 8.3 PLASTIC PREFILLED SYRINGES
    IMPROVED SAFETY, COST-EFFECTIVENESS, VERSATILITY, AND CONVENIENCE OF PLASTIC SYRINGES TO SUPPORT ADOPTION
PREFILLED SYRINGES MARKET, BY APPLICATION
111
  • 9.1 INTRODUCTION
  • 9.2 DIABETES
    INCREASING PREVALENCE OF DIABETES TO FAVOR MARKET GROWTH
  • 9.3 RHEUMATOID ARTHRITIS
    RISING DEMAND FOR EFFECTIVE AND CONVENIENT TREATMENT OPTIONS FOR RHEUMATOID ARTHRITIS TO DRIVE MARKET
  • 9.4 ANAPHYLAXIS
    CONVENIENCE OF PREFILLED SYRINGES TO ADMINISTER MEDICATION QUICKLY DURING ANAPHYLACTIC EPISODES TO BOOST GROWTH
  • 9.5 CANCER
    RISING GLOBAL CANCER RATES TO SUPPORT MARKET GROWTH
  • 9.6 THROMBOSIS
    MINIMIZED RISK OF CONTAMINATION AND INFECTION ASSOCIATED WITH PREFILLED SYRINGES TO DRIVE DEMAND
  • 9.7 OPHTHALMOLOGY
    FEWER SIDE-EFFECTS ASSOCIATED WITH PREFILLED SYRINGES COMPARED TO TOPICAL MEDICATIONS TO SUPPORT GROWTH
  • 9.8 OTHER APPLICATIONS
PREFILLED SYRINGES MARKET, BY REGION
123
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - US to dominate North American prefilled syringes market
    CANADA
    - Increasing government support and rising incidence of chronic diseases to drive market
  • 10.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Germany to dominate market in Europe
    UK
    - Growing number of CVD and diabetes patients to drive market growth
    FRANCE
    - Increasing needlestick injuries and growing trend of self-administration to drive market growth
    SPAIN
    - Increase in biologics production to support market growth
    ITALY
    - Growing focus of pharmaceutical and medical device companies to boost market growth
    REST OF EUROPE (ROE)
  • 10.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    JAPAN
    - Increased geriatric population and favorable government initiatives to drive market growth in Japan
    CHINA
    - Rising prevalence of chronic diseases to augment market growth
    INDIA
    - High incidence of cancer and increased adoption of biosimilars to fuel market growth
    AUSTRALIA
    - Growing healthcare expenditure to aid market growth
    SOUTH KOREA
    - Well-developed healthcare sector and presence of major pharmaceutical manufacturers to drive market
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - Rising incidence of chronic diseases and increasing obesity to augment market growth
    MEXICO
    - Increasing focus of government on healthcare and growing medical tourism to propel market
    ARGENTINA
    - Increasing focus of government on healthcare and growing medical tourism to propel market
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    GROWING PUBLIC HEALTHCARE SPENDING TO BOOST MARKET
    MIDDLE EAST & AFRICA: RECESSION IMPACT
  • 10.7 GCC COUNTRIES
    INCREASING HEALTHCARE EXPENDITURE TO DRIVE MARKET
    GCC COUNTRIES: RECESSION IMPACT
COMPETITIVE LANDSCAPE
200
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PREFILLED SYRINGES MARKET
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Type footprint
    - Material footprint
    - Design footprint
    - Application footprint
    - Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
  • 11.7 BRAND/PRODUCT COMPARISON
    BD
    GERRESHEIMER AG
    STEVANATO GROUP
    SCHOTT GROUP
    NIPRO
  • 11.8 R&D EXPENDITURE
  • 11.9 COMPETITIVE SITUATION
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
  • 11.10 COMPANY VALUATION & FINANCIAL METRICS
COMPANY PROFILES
229
  • 12.1 KEY PLAYERS
    BD
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    GERRESHEIMER AG
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SCHOTT
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    WEST PHARMACEUTICAL SERVICES, INC.
    - Business overview
    - Products offered
    - Recent developments
    APTARGROUP, INC.
    - Business overview
    - Products offered
    - Recent developments
    NIPRO
    - Business overview
    - Products offered
    BAXTER (SIMTRA)
    - Business overview
    - Products offered
    - Recent developments
    OWEN MUMFORD LTD.
    - Business overview
    - Products offered
    - Recent developments
    WEIGAO MEDICAL INTERNATIONAL CO., LTD
    - Business overview
    - Products offered
    CREDENCE MEDSYSTEMS, INC.
    - Business overview
    - Products offered
    NOVARTIS AG
    - Business overview
    - Products offered
    - Recent developments
    STEVANATO GROUP
    - Business overview
    - Products offered
    - Recent developments
    POLYMEDICURE
    - Business overview
    - Products offered
    MEDXL INC.
    - Business overview
    - Products offered
    SHARPS TECHNOLOGY, INC.
    - Business overview
    - Products offered
  • 12.2 OTHER PLAYERS
    FRESENIUS KABI USA
    MEDEFIL, INC.
    D.B.M. S.R.L.
    TAISEI KAKO CO., LTD.
    SHANDONG PROVINCE MEDICINAL GLASS CO., LTD.
    SHIN YAN SHENO PRECISION INDUSTRIAL CO., LTD.
    J.O. PHARMA CO., LTD. (OTSUKA HOLDINGS CO., LTD.)
    BMI KOREA
    B. BRAUN SE
    AL SHIFA MEDICAL PRODUCTS CO.
APPENDIX
284
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 RISK ASSESSMENT: PREFILLED SYRINGES MARKET
  • TABLE 3 PREFILLED SYRINGES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 AVERAGE SELLING PRICE OF PREFILLED SYRINGES, BY TYPE, 2022–2024 (USD)
  • TABLE 10 AVERAGE SELLING PRICE OF CONVENTIONAL PREFILLED SYRINGES, BY REGION, 2022–2024 (USD)
  • TABLE 11 AVERAGE SELLING PRICE OF SAFETY PREFILLED SYRINGES, BY REGION, 2022–2024 (USD)
  • TABLE 12 PREFILLED SYRINGES MARKET: ECOSYSTEM ANALYSIS
  • TABLE 13 IMPORT DATA FOR PREFILLED SYRINGES (HS CODE 90183100), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 14 EXPORT DATA FOR PREFILLED SYRINGES (HS CODE 90183100), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 15 LIST OF PATENTS IN PREFILLED SYRINGES MARKET (2022−2024)
  • TABLE 16 PREFILLED SYRINGES MARKET: KEY CONFERENCES & EVENTS (2024–2025)
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PREFILLED SYRINGES
  • TABLE 18 KEY BUYING CRITERIA FOR PREFILLED SYRINGES
  • TABLE 19 PRODUCT ANALYSIS OF KEY PLAYERS IN PREFILLED SYRINGE COMPONENTS
  • TABLE 20 PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 21 CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 22 CONVENTIONAL PREFILLED SYRINGES MARKET, BY REGION, 2022–2030 (MILLION UNITS)
  • TABLE 23 CONVENTIONAL PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 24 DISPOSABLE PREFILLED SYRINGES MARKET, BY REGION, 2022–2030 (MILLION UNITS)
  • TABLE 25 DISPOSABLE PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 26 REUSABLE PREFILLED SYRINGES MARKET, BY REGION, 2022–2030 (MILLION UNITS)
  • TABLE 27 REUSABLE PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 28 SAFETY PREFILLED SYRINGES MARKET, BY REGION, 2022–2030 (MILLION UNITS)
  • TABLE 29 SAFETY PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 30 PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 31 SINGLE-CHAMBER PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 32 DUAL-CHAMBER PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 33 CUSTOMIZED PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 34 PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 35 GLASS PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 36 PLASTIC PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 37 PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 38 PREFILLED SYRINGES MARKET FOR DIABETES APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 39 PREFILLED SYRINGES MARKET FOR RHEUMATOID ARTHRITIS APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 40 PREFILLED SYRINGES MARKET FOR ANAPHYLAXIS APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 41 PREFILLED SYRINGES MARKET FOR CANCER APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 42 PREFILLED SYRINGES MARKET FOR THROMBOSIS APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 43 PREFILLED SYRINGES MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 44 PREFILLED SYRINGES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 45 PREFILLED SYRINGES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 47 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 48 NORTH AMERICA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 49 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 50 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 51 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 52 US: KEY MACROINDICATORS
  • TABLE 53 US: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 54 US: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 55 US: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 56 US: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 57 US: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 58 CANADA: KEY MACROINDICATORS
  • TABLE 59 CANADA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 60 CANADA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 61 CANADA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 62 CANADA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 63 CANADA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 64 EUROPE: PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 65 EUROPE: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 66 EUROPE: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 67 EUROPE: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 68 EUROPE: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 69 EUROPE: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 70 GERMANY: KEY MACROINDICATORS
  • TABLE 71 GERMANY: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 72 GERMANY: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 73 GERMANY: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 74 GERMANY: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 75 GERMANY: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 76 UK: KEY MACROINDICATORS
  • TABLE 77 UK: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 78 UK: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 79 UK: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 80 UK: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 81 UK: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 82 FRANCE: KEY MACROINDICATORS
  • TABLE 83 FRANCE: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 84 FRANCE: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 85 FRANCE: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 86 FRANCE: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 87 FRANCE: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 88 SPAIN: KEY MACROINDICATORS
  • TABLE 89 SPAIN: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 90 SPAIN: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 91 SPAIN: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 92 SPAIN: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 93 SPAIN: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 94 ITALY: KEY MACROINDICATORS
  • TABLE 95 ITALY: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 96 ITALY: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 97 ITALY: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 98 ITALY: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 99 ITALY: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 100 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 101 REST OF EUROPE: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 102 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 103 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 104 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 111 JAPAN: KEY MACROINDICATORS
  • TABLE 112 JAPAN: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 113 JAPAN: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 114 JAPAN: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 115 JAPAN: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 116 JAPAN: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 117 CHINA: KEY MACROINDICATORS
  • TABLE 118 CHINA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 119 CHINA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 120 CHINA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 121 CHINA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 122 CHINA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 123 INDIA: KEY MACROINDICATORS
  • TABLE 124 INDIA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 125 INDIA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 126 INDIA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 127 INDIA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 128 INDIA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 129 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 130 AUSTRALIA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 131 AUSTRALIA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 132 AUSTRALIA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 133 AUSTRALIA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 134 AUSTRALIA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 135 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 136 SOUTH KOREA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 137 SOUTH KOREA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 138 SOUTH KOREA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 139 SOUTH KOREA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 140 SOUTH KOREA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 141 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 142 REST OF ASIA PACIFIC: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 143 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 144 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 145 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 146 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 147 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 148 LATIN AMERICA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 149 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 150 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 151 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 152 BRAZIL: KEY MACROINDICATORS
  • TABLE 153 BRAZIL: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 154 BRAZIL: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 155 BRAZIL: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 156 BRAZIL: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 157 BRAZIL: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 158 MEXICO: KEY MACROINDICATORS
  • TABLE 159 MEXICO: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 160 MEXICO: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 161 MEXICO: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 162 MEXICO: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 163 MEXICO: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 164 ARGENTINA: KEY MACROINDICATORS
  • TABLE 165 ARGENTINA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 166 ARGENTINA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 167 ARGENTINA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 168 ARGENTINA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 169 ARGENTINA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 170 REST OF LATIN AMERICA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 171 REST OF LATIN AMERICA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 172 REST OF LATIN AMERICA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 173 REST OF LATIN AMERICA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 174 REST OF LATIN AMERICA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 175 MIDDLE EAST & AFRICA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 176 MIDDLE EAST & AFRICA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 178 MIDDLE EAST & AFRICA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 180 GCC COUNTRIES: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 181 GCC COUNTRIES: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 182 GCC COUNTRIES: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION)
  • TABLE 183 GCC COUNTRIES: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION)
  • TABLE 184 GCC COUNTRIES: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 185 PREFILLED SYRINGES MARKET: DEGREE OF COMPETITION
  • TABLE 186 PREFILLED SYRINGES MARKET: TYPE FOOTPRINT
  • TABLE 187 PREFILLED SYRINGES MARKET: MATERIAL FOOTPRINT
  • TABLE 188 PREFILLED SYRINGES MARKET: DESIGN FOOTPRINT
  • TABLE 189 PREFILLED SYRINGES MARKET: APPLICATION FOOTPRINT
  • TABLE 190 PREFILLED SYRINGES MARKET: REGION FOOTPRINT
  • TABLE 191 PREFILLED SYRINGES MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 192 PREFILLED SYRINGES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS
  • TABLE 193 PREFILLED SYRINGES MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 194 PREFILLED SYRINGES MARKET: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 195 PREFILLED SYRINGES MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 196 BD: COMPANY OVERVIEW
  • TABLE 197 BD: PRODUCTS OFFERED
  • TABLE 198 BD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 199 BD: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 200 BD: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 201 GERRESHEIMER AG: COMPANY OVERVIEW
  • TABLE 202 GERRESHEIMER AG: PRODUCTS OFFERED
  • TABLE 203 GERRESHEIMER AG: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 204 GERRESHEIMER AG: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 205 SCHOTT: COMPANY OVERVIEW
  • TABLE 206 SCHOTT: PRODUCTS OFFERED
  • TABLE 207 SCHOTT: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 208 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW
  • TABLE 209 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS OFFERED
  • TABLE 210 WEST PHARMACEUTICAL SERVICES, INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 211 WEST PHARMACEUTICAL SERVICES, INC.: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 212 APTARGROUP, INC.: COMPANY OVERVIEW
  • TABLE 213 APTARGROUP, INC.: PRODUCTS OFFERED
  • TABLE 214 APTARGROUP, INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 215 APTARGROUP, INC.: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 216 NIPRO: COMPANY OVERVIEW
  • TABLE 217 NIPRO: PRODUCTS OFFERED
  • TABLE 218 BAXTER (SIMTRA): COMPANY OVERVIEW
  • TABLE 219 BAXTER (SIMTRA): PRODUCTS OFFERED
  • TABLE 220 BAXTER (SIMTRA): DEALS, JANUARY 2021–JUNE 2024
  • TABLE 221 BAXTER (SIMTRA): EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 222 OWEN MUMFORD LTD.: COMPANY OVERVIEW
  • TABLE 223 OWEN MUMFORD LTD.: PRODUCTS OFFERED
  • TABLE 224 OWEN MUMFORD LTD.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 225 OWEN MUMFORD LTD.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 226 WEIGAO MEDICAL INTERNATIONAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 227 WEIGAO MEDICAL INTERNATIONAL CO., LTD.: PRODUCTS OFFERED
  • TABLE 228 CREDENCE MEDSYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 229 CREDENCE MEDSYSTEMS, INC.: PRODUCTS OFFERED
  • TABLE 230 NOVARTIS AG: COMPANY OVERVIEW
  • TABLE 231 NOVARTIS AG: PRODUCTS OFFERED
  • TABLE 232 NOVARTIS AG: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 233 STEVANATO GROUP: COMPANY OVERVIEW
  • TABLE 234 STEVANATO GROUP: PRODUCTS OFFERED
  • TABLE 235 STEVANATO GROUP: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 236 STEVANATO GROUP: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 237 STEVANATO GROUP: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 238 POLYMEDICURE: COMPANY OVERVIEW
  • TABLE 239 POLYMEDICURE: PRODUCTS OFFERED
  • TABLE 240 MEDXL INC.: COMPANY OVERVIEW
  • TABLE 241 MEDXL INC.: PRODUCTS OFFERED
  • TABLE 242 SHARPS TECHNOLOGY, INC.: COMPANY OVERVIEW
  • TABLE 243 SHARPS TECHNOLOGY, INC.: PRODUCTS OFFERED
LIST OF FIGURES
 
  • FIGURE 1 PREFILLED SYRINGES MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: BD (2023)
  • FIGURE 9 PREFILLED SYRINGES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION (2023)
  • FIGURE 10 PREFILLED SYRINGES MARKET: TOP-DOWN APPROACH
  • FIGURE 11 CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS (2024–2030)
  • FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 PREFILLED SYRINGES MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 15 CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 PREFILLED SYRINGES MARKET, BY MATERIAL, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 PREFILLED SYRINGES MARKET, BY DESIGN, 2024 VS. 2030 (USD MILLION)
  • FIGURE 18 PREFILLED SYRINGES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 19 GEOGRAPHIC SNAPSHOT OF PREFILLED SYRINGES MARKET
  • FIGURE 20 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE GROWTH IN PREFILLED SYRINGES MARKET
  • FIGURE 21 CONVENTIONAL PREFILLED SYRINGES ACCOUNTED FOR LARGEST SHARE OF APAC PREFILLED SYRINGES MARKET IN 2023
  • FIGURE 22 NORTH AMERICA TO DOMINATE MARKET THROUGHOUT FORECAST PERIOD
  • FIGURE 23 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 24 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 25 PREFILLED SYRINGES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 PREFILLED SYRINGES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 27 PREFILLED SYRINGES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 28 PREFILLED SYRINGES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 ADJACENT MARKETS TO PREFILLED SYRINGES MARKET
  • FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN PREFILLED SYRINGES MARKET
  • FIGURE 31 GLOBAL PATENT PUBLICATION TRENDS (JANUARY 2014–JUNE 2024)
  • FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PREFILLED SYRINGES
  • FIGURE 33 KEY BUYING CRITERIA FOR PREFILLED SYRINGES, BY TYPE
  • FIGURE 34 INVESTMENT/VENTURE CAPITAL SCENARIO IN PREFILLED SYRINGES MARKET, 2021–2024
  • FIGURE 35 PREFILLED SYRINGES MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 36 NORTH AMERICA: PREFILLED SYRINGES MARKET SNAPSHOT
  • FIGURE 37 EUROPE: PREFILLED SYRINGES MARKET SNAPSHOT
  • FIGURE 38 ASIA PACIFIC: PREFILLED SYRINGES MARKET SNAPSHOT
  • FIGURE 39 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES
  • FIGURE 40 PREFILLED SYRINGES MARKET: REVENUE ANALYSIS, 2019–2023
  • FIGURE 41 PREFILLED SYRINGES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2023
  • FIGURE 42 PREFILLED SYRINGES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 43 PREFILLED SYRINGES MARKET: COMPANY FOOTPRINT
  • FIGURE 44 PREFILLED SYRINGES MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  • FIGURE 45 PREFILLED SYRINGES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 46 R&D EXPENDITURE OF KEY PLAYERS, 2022 VS. 2023
  • FIGURE 47 EV/EBITDA OF KEY VENDORS
  • FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 49 BD: COMPANY SNAPSHOT (2023)
  • FIGURE 50 GERRESHEIMER AG: COMPANY SNAPSHOT (2023)
  • FIGURE 51 SCHOTT: COMPANY SNAPSHOT (2023)
  • FIGURE 52 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 53 APTARGROUP, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 54 NIPRO: COMPANY SNAPSHOT (2023)
  • FIGURE 55 BAXTER (SIMTRA): COMPANY SNAPSHOT (2023)
  • FIGURE 56 WEIGAO MEDICAL INTERNATIONAL CO., LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 57 NOVARTIS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 58 STEVANATO GROUP: COMPANY SNAPSHOT (2023)
  • FIGURE 59 POLYMEDICURE: COMPANY SNAPSHOT (2023)

This study involved four major activities in estimating the current prefilled syringes market size. Exhaustive secondary research was done to collect information on the market, peer market and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the prefilled syringes market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the prefilled syringes market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents for the prefilled syringes market is provided below:

Prefilled Syringes Market Size, and Share

Note 1: C-level primaries include CEOs, COOs, and CTOs.

Note 2: Others include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=<USD 500 million

To know about the assumptions considered for the study, download the pdf brochure

The research methodology used to estimate the size of the market includes the following details.

The market sizing of the market was undertaken from the global side.

Country-level Analysis: The size of the prefilled syringes market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall prefilled syringes market was obtained from secondary data and validated by primary participants to arrive at the total prefilled syringes market. Primary participants further validated the numbers.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by prefilled syringes and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall prefilled syringes market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Prefilled Syringes Market Size: Top-Down Approach

Prefilled Syringes Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Prefilled Syringes Market Size: Bottom-Up Approach

Prefilled Syringes Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Prefilled syringes are a convenient way to deliver parenteral medications or a single-dose packet of medication with a premeasured dose. This method of drug administration offers advantages for manufacturers in terms of reducing drug waste and extending product lifespan. Additionally, it provides ease of self-administration for patients at home and in non-hospital settings. Some examples of drugs packaged in prefilled syringes include biologics, vaccines, blood stimulants, therapeutic proteins, erythropoietin products, and interferons.

Key Stakeholders

  • Product manufacturers, distributors, and suppliers
  • Research laboratories
  • Academic universities and medical research centers
  • R&D centers
  • Business research and consulting firms
  • Biotechnology companies
  • Hospitals
  • Clinical centers
  • Pharmaceutical companies
  • Medical research laboratories
  • Consulting firms

Objectives of the Study

  • To describe, analyze, and forecast the prefilled syringes market by type, design, material, application, and region.
  • To describe and forecast the prefilled syringes market for key regions—North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries.
  • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the prefilled syringes market.
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market.
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players.
  • To profile key players and comprehensively analyze their market shares and core competencies2 in the prefilled syringes market.
  • To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the prefilled syringes market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis
  • Further breakdown of the Rest of Europe prefilled syringes market into Belgium, Russia, the Netherlands, Switzerland, and other countries.
  • Further breakdown of the Rest of Asia Pacific prefilled syringes market into Indonesia, Philippines, Vietnam, Hong Kong, and other countries
  • Further breakdown of the Rest of Latin America prefilled syringes market into Colombia, Peru, and other countries.

Previous Versions of this Report

Prefilled Syringes Market by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) - Global Forecast to 2025

Report Code MD 4755
Published in Sep, 2020, By MarketsandMarkets™

Prefilled Syringes Market by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) - Global Forecast to 2025

Report Code MD 4755
Published in Nov, 2016, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Prefilled Syringes Market

DMCA.com Protection Status